SherpaBonds
US78081BAL71 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 3.30% 2040/09

Royalty Pharma PlcUnited KingdomGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
77.51
par = 100
YIELD TO MAT.
5.68%
semi-annual
COUPON
3.300%
semi-annual · fixed
MATURITY
2040-09-02
bullet · 14.32y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
10.66 y
1bp ↑ ≈ -0.107% P&L
Convexity
140.13
higher = more curvature
Years to maturity
14.32 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Vanguard Total Bond Market
Vanguard
US Aggregate$8.7M—0.00%2026-03-31
iShares iBoxx $ Investment Grade Corporate Bond
iShares
US IG Corporate$6.2M▼ $35K0.02%2026-05-07
Vanguard Long-Term Corporate Bond
Vanguard
US Corporate Long$5.3M—0.07%2026-03-31
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$3.7M▼ $18K0.00%2026-05-07
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.5M▼ $7K0.01%2026-05-07
Vanguard Long-Term Bond
Vanguard
US Aggregate Long$1.5M—0.02%2026-03-31
iShares Core Universal USD Bond
iShares
US Aggregate$938K▼ $5K0.00%2026-05-07
iShares 10+ Year Investment Grade Corporate Bond
iShares
US IG Corporate$903K▼ $4K0.03%2026-05-07
iShares Investment Grade Systematic Bond
iShares
US IG Corporate$462K▼ $2K0.03%2026-05-07
SPDR Portfolio Long Term Corporate Bond
SPDR
US IG Corporate Long$108K▲ $4890.01%2026-05-05
iShares Interest Rate Hedged Corporate Bond
iShares
US IR Hedged IG Corporate$100K▼ $1K0.02%2026-05-07
iShares ESG Aware USD Corporate Bond
iShares
US ESG IG Corporate$97K▼ $4720.01%2026-05-07
iShares Core 10+ Year USD Bond
iShares
US Aggregate$89K▼ $4350.02%2026-05-07
iShares Interest Rate Hedged Long-Term Corporate Bond
iShares
US IG Corporate Hedged$54K▼ $2920.03%2026-05-07
iShares BBB Rated Corporate Bond
iShares
US IG Corporate$27K▲ $4K0.05%2026-05-07
iShares ESG Advanced Universal USD Bond
iShares
US Aggregate$27K▼ $1320.00%2026-05-07
iShares Inflation Hedged Corporate Bond
iShares
US IG Corporate$14K▼ $1830.02%2026-05-07
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$135—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

64/ 100Broad ownership
Interpretation. Moderate institutional footprint, with net accumulation
HOLDERS
18
▲ 8 signals in 7d
AGGREGATE EXPOSURE
$29.8M
USD across all
TOP CONCENTRATION
29.2%
largest holder
FLOW
▲ $2.5M
▲ 8 signals in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
77,506 USD
PRICE
77.51

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 3.3 09/02/40
FIGI
BBG011Q57ZM7
CUSIP
78081BAL7
ISIN
US78081BAL71
Type
Corp
Issued
2021-03-02
Face value
100 USD
Ticker
RPRX 3.3 09/02/40
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 3.55% 09/2050
Royalty Pharma Plc
2050-09
6.00%
+32 bps yield+10y duration13 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
−40 bps yield−5y duration9 signals in commonSame issuer
Royalty Pharma Plc 2.15% 09/2031
Royalty Pharma Plc
2031-09
4.78%
−90 bps yield−9y duration6 signals in commonSame issuer
Royalty Pharma Plc 3.35% 09/2051
Royalty Pharma Plc
2051-09
5.95%
+27 bps yield+11y duration9 signals in commonSame issuer
Royalty Pharma Plc 5.9% 09/2054
Royalty Pharma Plc
2054-09
6.03%
+35 bps yield+14y duration10 signals in commonSame issuer
Royalty Pharma Plc 5.95% 09/2055
Royalty Pharma Plc
2055-09
6.05%
+37 bps yield+15y duration8 signals in commonSame issuer